Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression
- PMID: 1374113
- DOI: 10.3109/08830189209056642
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression
Abstract
An attempt is made to summarize the evidence that humoral immune responses in natural HIV-1 infection play a role in clearance of the initial burst of replication as well as in protection against rapid disease progression. Therefore, the so-called "asymptomatic carrier state" was defined on the basis of immunological characteristics, such as CD4+ cell number, CD45RA-CD29+ cell number, CD4+ proliferative responses to anti-CD3 mAbs and soluble activation markers, as well as virological characteristics such as the state of the viral genome in the cell, levels of genomic RNA production, antigenemia, viremia and virus phenotype. During natural infection two major classes HIV-1 neutralizing and cell-fusion inhibiting antibodies are elicited. One population directed against mostly continuous epitopes localized in the third variable domain (V3) of the envelope and one against discontinuous epitopes of the envelope. The last population blocks gp120-CD4 attachment, the first does not. The role of each of these populations of functional antibodies, in the clearance of viremia and the maintenance of the asymptomatic carrier state is discussed.
Similar articles
-
How antibodies block HIV infection: paths to an AIDS vaccine.Trends Biochem Sci. 1992 May;17(5):191-6. doi: 10.1016/0968-0004(92)90265-b. Trends Biochem Sci. 1992. PMID: 1350693 Review.
-
HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.Virus Genes. 1994 Jul;8(3):249-70. doi: 10.1007/BF01704519. Virus Genes. 1994. PMID: 7975271 Review.
-
Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):213-20. doi: 10.1097/00042560-199607000-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673525
-
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.Vaccine. 1994 Sep;12(12):1141-8. doi: 10.1016/0264-410x(94)90185-6. Vaccine. 1994. PMID: 7998425
-
CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):128-36. doi: 10.1097/00042560-199602010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8556394
Cited by
-
A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization.J Virol. 1993 Apr;67(4):2202-8. doi: 10.1128/JVI.67.4.2202-2208.1993. J Virol. 1993. PMID: 8383237 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials